RESUMO
BACKGROUND: The therapeutic efficacy of red blood cell (RBC) transfusions in patients with autoimmune hemolytic anemia (AIHA) is highly debated because of speculations on the increased risk of transfusion reactions; yet it is a suggested adjuvant therapy in anemic patients with life-threatening hypoxemia. In this study, we evaluated the safety and efficacy of RBC transfusions in AIHA patients. METHODS: Daily changes in hemoglobin, total bilirubin, and lactate dehydrogenase (LDH) were assessed in 161 AIHA patients without bleeding history who were transfused once with 1-5 units of the least-incompatible RBCs and monitored over a seven-day period. Post-transfusion patients positive for alloantibodies only or those without RBC-specific antibodies were considered as control groups (N=100 for both groups). RESULTS: The three groups revealed similar increases in hemoglobin of 1.40-1.70 g/dL (autoantibodies), 1.20-1.60 g/dL (alloantibodies only), and 1.40-1.55 g/dL (no antibodies) for seven days following transfusion of 10 mL RBCs/kg. During follow-up, no significant changes in total bilirubin or LDH levels were detected in the AIHA group compared with controls. Influences due to autoantibody type, direct antiglobulin test (DAT) specificity and strength, and steroid therapy status on transfusion reactions were not evident in AIHA patients. In addition, changes in hemoglobin levels were significantly higher (P<0.001) in severe anemia (<5 g/dL) than in other patients. CONCLUSIONS: Transfusion of the least-incompatible RBCs in AIHA patients is effective and safe without any associated increase in hemolysis risk when compared with post-transfusion patients positive for alloantibodies or those lacking RBC-specific antibodies.
Assuntos
Humanos , Anemia , Anemia Hemolítica Autoimune , Hipóxia , Anticorpos , Autoanticorpos , Bilirrubina , Incompatibilidade de Grupos Sanguíneos , Teste de Coombs , Transfusão de Eritrócitos , Eritrócitos , Seguimentos , Hemólise , Hemorragia , Isoanticorpos , L-Lactato DesidrogenaseRESUMO
BACKGROUND: Although therapeutic plasmapheresis (TP) is a useful procedure in removing pathogenic antibodies and toxic substances from the patient, adverse reactions could arise from the use of replacement fluids and anticoagulants. Comprehensive analysis on those adverse effects had been rarely reported in Korea. METHODS: We retrospectively investigated the clinical records and the TP records from 3,962 TP sessions for 581 patients between January 1995 and October 2008 at Asan Medical Center, and we analyzed the adverse reactions related to TP. RESULTS: Adverse reactions were seen in 142 patients (24.4%) in 348 TP procedures (8.8%). Citrate toxicity was most frequently seen in 83 procedures (23.9%) followed by chills in 72 procedures (20.7%), allergic reactions in 69 procedures (19.8%) and hypotension in 60 procedures (17.2%). Citrate toxicity, chills and allergic reactions were seen more frequently in the TP procedures using FFP than in the TP procedures using albumin (P=0.001). The prevalence of citrate toxicity was significantly lower in the cases where calcium gluconate was administered (P<0.001), while it was significantly higher in the patients whose hematocrit was below 28.5% (P<0.001). In terms of severity, the mild, moderate and severe adverse reactions were 36.8%, 56.3% and 6.9%, respectively. CONCLUSION: TP is a relatively safe method of treatment, but it is important to predict and prevent adverse reactions and to respond appropriately to these adverse reactions.
Assuntos
Humanos , Anticorpos , Anticoagulantes , Gluconato de Cálcio , Calafrios , Ácido Cítrico , Gluconatos , Hematócrito , Hipersensibilidade , Hipotensão , Plasmaferese , Prevalência , Estudos RetrospectivosRESUMO
BACKGROUND: Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality in transplant recipients and immunocompromised patients. We compared the results of a dual polymerase chain reaction (dual-PCR) and an antigenemia (Ag) test for detection of CMV from blood samples. METHODS: Between February 2002 and May 2005, we analyzed 175 blood samples submitted for CMV tests at Hanyang University Hospital. The late antigen (LA) and major immediate early (MIE) genes of CMV were concurrently amplified in the dual-PCR. The lower matrix protein pp65 of CMV was detected for the Ag test (Chemicon, Temecula, CA, USA). RESULTS: The positive rate of the dual-PCR was 14.3% (25/175) and that of the Ag test was 13.1% (23/175). The concordance rate of the dual-PCR and Ag test was 85.1% (149/175), while the discordance rate was 14.9% (26/175). CONCLUSION: The dual-PCR is a useful method for the early detection of CMV, but we recommend using both the dual-PCR and Ag test for detection of CMV due to a high discordance rate of the two methods.
Assuntos
Citomegalovirus , Hospedeiro Imunocomprometido , Mortalidade , Reação em Cadeia da Polimerase , TransplanteRESUMO
Nocardia species are opportunistic pathogens that are known to affect mostly the immunocompromised patients. Recently, we experienced a young systemic lupus erythromatosus female patient having infected with Nocardia species, which we were able to isolate from her lung abscess. The patient is twenty-nine years old female who was diagnosed as having systemic lupus erythromatosus two years ago and is currently engaged with ongoing treatment. During her admission, new symptoms of fever and dyspnea along with a lesion in the apical lobe of her left lung found by simple chest X-rays were observed. Under lung biopsy examination, there were seen neutrophilic exudates that were gram-positive, AFB-negative, and modified AFB-positive. By culturing the biopsy material, we found gram-positive, AFB-negative, and modified AFB-positive branching hyphaes that were morphologically matched for Nocardia species. We have analyzed the Nocardia DNA by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and found the organism to be Nocardia asteroides type I. Treatment of patient was done using sulfamethoxazole/trimethoprim and ceftriazone, and her clinical conditions as well as her radiological findings improved.
Assuntos
Feminino , Humanos , Biópsia , DNA , Dispneia , Exsudatos e Transudatos , Febre , Hifas , Hospedeiro Imunocomprometido , Pulmão , Abscesso Pulmonar , Neutrófilos , Nocardia , Nocardia asteroides , Pneumonia , Reação em Cadeia da Polimerase , TóraxRESUMO
Mycobacterium abscessus is one of the species of rapidly growing mycobacteria that is widely distributed in nature. Using PCR-RFLP method, we have isolated 5 cases of M. abscessus from the soft tissue, sputum and blood, and further investigated each patient's clinical courses and the results of the treatment. Three of the five patients had soft tissue infections, while the other two had pulmonary infections. Among the patients with soft tissue infections, two had a past history of steroid injection and the other had a trauma history. The clinical courses of these patients deteriorated quickly and they did not respond to the common anti-microbial antibiotics treatment. One of the two pulmonary infection patients, who had a past history of pulmonary tuberculosis and diabetes mellitus, had a more severe clinical course and difficulty on treatment than the patient who did not have a significant past history. M. abscessus can cause disseminated infection in immunocompromised patients and it most likely becomes resistant to antituberculous drug, therefore it is utmost necessary to perform rapid species identification and antibiotics susceptibility test.